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Modification with arginine-specific glyoxals modulates the
permeability transition (PT) of rat liver mitochondria, with
inhibitory or inducing effects that depend on the net charge of
the adduct(s). Here, we show that phenylglyoxal (PGO) affects
the PT in a species-specific manner (inhibition in mouse and
yeast, induction in human and Drosophila mitochondria). Fol-
lowing the hypotheses (i) that the effects are mediated by con-
served arginine(s) and (ii) that the PT is mediated by the F-ATP
synthase, we have narrowed the search to 60 arginines. Most of
these residues are located in subunits , , , , a, and c and were
excluded because PGO modification did not significantly
affect enzyme catalysis. On the other hand, yeast mitochon-
dria lacking subunit g or bearing a subunit g R107A mutation
were totally resistant to PT inhibition by PGO. Thus, the
effect of PGO on the PT is specifically mediated by Arg-107,
the only subunit g arginine that has been conserved across
species. These findings are evidence that the PT is mediated
by F-ATP synthase.
The mitochondrial PT3 is a Ca2-dependent permeability
increase of the inner membrane (1). The PT is mediated by
opening of a regulated channel, the permeability transition pore
(PTP), which coincides with the mitochondrial megachannel
(MMC) identified by electrophysiology (2, 3). The mammalian
PTP/MMC displays a range of conductance states, which can
be as high as 1.2 nanosiemens, corresponding to a pore with a
diameter of about 2 nm. The channel also visits lower conduc-
tance states that may be the basis for selective permeation of
small solutes (4). Depending on open time and channel size, the
PTP/MMC can participate in Ca2 homeostasis (short-term
and/or low-conductance openings that provide a pathway for
fast Ca2 release) (5) or cell death (long-lasting and/or high-
conductance openings that cause energy dissipation, mem-
brane permeabilization to solutes, matrix swelling, and outer
membrane rupture with release of proapoptotic proteins) (6).
The mammalian PTP is modulated by binding of cyclophilin D
(CyPD), which favors pore opening after matrix accumulation
of Ca2, an essential permissive factor (7). Regulation of the
PTP is complex; opening is favored by CyPD, Pi, and oxidative
stress, whereas it is inhibited by matrix H, Mg2, adenine
nucleotides, and cyclosporin A, which displaces CyPD and
desensitizes the pore to Ca2 (8). Although the molecular com-
ponents of the PTP were unknown, a few discrete regulatory
sites have been defined in the 1990s through the use of modifi-
ers of SH groups and of relatively specific histidine and arginine
reagents (9 –15).
The most recent hypothesis about the molecular nature of
the PTP/MMC is that it originates from a conformational
change occurring on F-ATP synthase when Mg2 is replaced by
Ca2 at the catalytic site. The conformational change would be
transmitted to the inner membrane by the peripheral stalk,
causing pore formation at the interface between enzyme mono-
mers (7). Whether and how the F-ATP synthase can form chan-
nels is the matter of controversy. The hypothesis is supported
by genetic manipulation of F-ATP synthase (16, 17); by electro-
physiological measurements of the bovine, human, yeast, and
Drosophila enzymes (17–20); and by site-directed mutagenesis
of specific F-ATP synthase residues (21, 22), whereas it has been
questioned by studies based on genetic ablation of subunits c, b,
and OSCP (23, 24) (see Bernardi and Lippe (25) for a recent
discussion that covers this controversy and offers an explana-
tion for the apparent discrepancies).
The PTP response to Ca2 is modulated by arginine residues,
which upon modification with glyoxals can cause PTP sensiti-
zation or desensitization, depending on the specific reagent
(12–15). Previous studies have focused on the structure–
function relationship of glyoxals of different structure rather
than on the identification of the reactive residue(s) (12–15).
Here, we have found that the effect of phenylglyoxal (PGO) on
the PTP differs between species and used sequence comparison
This work was supported by AIRC Grant IG17067 (to P. B.) and Fondation
Leducq Grant 16CVD04 (to P. B.). The authors declare that they have no
conflicts of interest with the contents of this article.
1 Supported by a fellowship from the China Scholarship Council. This work is
in partial fulfillment of the requirements for the Ph.D. for this author at the
Department of Biomedical Sciences, University of Padova.
2 To whom correspondence should be addressed. Tel.: 39-049-827-6365; Fax:
39-049-827-6049; E-mail: bernardi@bio.unipd.it.
3 The abbreviations used are: PT, mitochondrial permeability transition; AGE,
advanced glycation end-products; CRC, Ca2 retention capacity; CyPD,
cyclophilin D; MGO, methylglyoxal; MLM, mouse liver mitochondria; MMC,
mitochondrial megachannel; PGO, phenylglyoxal; PTP, permeability tran-




14632 J. Biol. Chem. (2018) 293(38) 14632–14645













and mutagenesis to identify the unique arginine of F-ATP syn-
thase subunit g (of a total of 60 conserved residues) that medi-
ates the PTP-modulating effect of PGO in yeast. This finding is
a step forward in the molecular understanding of PTP regula-
tion and further supports the hypothesis that the PTP forms
from F-ATP synthase.
Results
The effects of PGO on the PTP have been conserved but differ
between species
Consistent with the effect of PGO on the PTP of rat liver
mitochondria, PGO desensitized the PTP to Ca2 in mouse
liver mitochondria (MLM) (Fig. 1A) as well as in mitochondria
from Saccharomyces cerevisiae in the presence of ETH129, a
selective ionophore that allows Ca2 equilibration across the
inner membrane in yeast mitochondria (Fig. 1B). In either case,
the desensitizing effect can be appreciated from the increased
Ca2 retention capacity (CRC) of PGO-treated mitochondria
(Fig. 1, A and B). Unexpectedly, PGO caused instead sensitiza-
tion of the pore to Ca2 in permeabilized human HEK293 (Fig.
1C) and Drosophila S2R cells (Fig. 1D). Sensitization of PTP
opening by PGO in human and Drosophila cells was not due to
digitonin permeabilization, as it was also observed in mito-
chondria isolated from these cells (results not shown). These
findings indicate that the ability to modulate the PTP by
PGO has been conserved across species. Under the assump-
tions (i) that the observed differences depend on specific
features of the PTP rather than on the existence of species-
specific reactive sites and (ii) that these sites are located on
the F-ATP synthase, we narrowed the search of the reactive
arginine(s) from 135 (yeast) to 60 arginines that are con-
served between F-ATP synthases of S. cerevisiae, Homo sapi-
ens, Mus musculus, and Drosophila melanogaster (the posi-
tions of these residues in the yeast, human, and mouse
enzymes are reported in Table 1).
Chemical modification by PGO does not affect catalytic
activity, oligomycin sensitivity, assembly, and subunit
composition of F-ATP synthase
Due to the large number of arginine residues and their spe-
cific relevance to enzymatic activity of F-ATP synthase, we
assessed whether treatment with PGO affects the catalytic
properties of the enzyme in MLM and yeast mitochondria
(YM). In MLM, a trend toward a slight inhibition of ATP hy-
drolysis was observed (but this did not reach statistical signifi-
cance), and the catalytic activity maintained its sensitivity to
oligomycin (Fig. 2A), and respiratory stimulation by ADP was
not affected (Fig. 2B). Similarly, in YM, both ATP hydrolytic
activity and respiratory stimulation by ADP were unaffected by
PGO (Fig. 2, C and D). Blue native gel separation and in-gel
activity staining after digitonin extraction did not reveal any
major effect of PGO on F-ATP synthase oligomeric state in
MLM (Fig. 2E). In these experiments, we used MLM because
they are easy to purify and because the mouse enzyme is virtu-
Figure 1. The sensitivity of PTP to PGO is conserved across species. Isolated mitochondria or permeabilized cells were pretreated with vehicle (DMSO) or
PGO and resuspended in the CRC assay buffer as described under “Experimental Procedures.” A, CRC of MLM pretreated with DMSO (black trace) or 1 mM PGO
(red trace). B, CRC of isolated yeast mitochondria pretreated with DMSO (black trace) or 4 mM PGO (red trace). C, CRC of permeabilized HEK293 cells pretreated
with DMSO (black trace) or 4 mM PGO (red trace). D, CRC of permeabilized Drosophila S2R
 cells pretreated with DMSO (black trace) or 1 mM PGO (red trace).
Representative traces are shown. Bars, CRC of DMSO- (black) or PGO-pretreated (red) isolated mitochondria or permeabilized cells. CRC of DMSO-treated
mitochondria was set as 1 unit. Results are mean  S.E. (error bars) of at least three independent experiments. *, p  0.05 versus vehicle; **, p  0.01 versus
vehicle. One-way ANOVA was used for statistical analysis.
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ally identical to the human and yeast species for composition of
conserved arginines (Table 1). Analysis of dimers and mono-
mers resolved by SDS-PAGE and silver staining demonstrated
that treatment with PGO did not alter the pattern and relative
abundance of F-ATP synthase subunits (Fig. 2F). Based on these
results, the arginine residues of the F1 sector, subunit a, and
c-ring were not investigated further. Taking advantage of the
yeast model and of the species-specific response to PGO, we
performed a set of mutagenesis experiments in yeast cells to
identify the arginine residue(s) conferring the modulatory
effect to PGO.
OSCP does not confer sensitivity to the effects of PGO
We first investigated whether OSCP, which contains two
conserved arginine residues (Table 1), could be involved in con-
ferring the species specificity to the effects of PGO, which are
opposite in human and yeast mitochondria (Fig. 1). Deletion of
the ATP5 gene encoding for OSCP (ATP5) prevented F-ATP
synthase assembly and growth on glycerol, both features being
rescued by reexpression of the WT yeast gene (ATP5 
yOSCP) (Fig. 3, A–C). Replacement with the human OSCP gene
(ATP5  hOSCP) was instead essentially unable to rescue
F-ATP synthase assembly unless the yeast mitochondrial tar-
geting sequence replaced the human sequence in the construct
(ATP5  yhOSCP). Indeed, only the chimeric protein allowed
assembly of a functional F-ATP synthase complex, which grew
normally on glycerol (Fig. 3, A–C). The rescued mutant dis-
played an increased CRC in response to PGO (i.e. the same
response of WT yeast mitochondria) (Fig. 3D). Thus, OSCP
does not confer species specificity to the effects of PGO on the
PTP.
Arginine 107 of yeast F-ATP synthase subunit g mediates the
effect of PGO on the mitochondrial permeability transition
Both subunit e and g possess a conserved arginine residue
(Arg-8 and Arg-107 in the yeast sequence, respectively, Fig. 4).
These residues correspond to Arg-15 and Arg-96, respectively,
in the human sequence (Table 1). To test whether these resi-
dues are involved in PTP modulation by PGO, we first analyzed
deletion mutants of subunit g (ATP20) and of subunit e
(TIM11). The effect of PGO was completely abolished in the
ATP20 deletion mutant lacking subunit g (Fig. 5A), and a sim-
ilar, albeit somewhat smaller, effect was observed with the
TIM11 mutant lacking subunit e (Fig. 5B). To explore the role
of individual arginines, we generated specific point mutants
and tested their CRC. Remarkably, the R107A mutation in sub-
unit g dramatically blunted the effect of PGO (Fig. 5C), whereas
the R8A mutation in subunit e was ineffective, with an identical
sensitivity to PGO as the WT species (Fig. 5D). This result was
puzzling because subunit e only has one conserved arginine in
position 8, and therefore we would have expected the same
result following either deletion of the subunit e gene or the
R8A mutation. This apparent contradiction was resolved by
analysis of the expression of the e and g subunits in the
ATP20 and TIM11 mutants. Indeed, deletion of the
ATP20 gene led to the expected disappearance of subunit g
only, whereas deletion of the TIM11 gene caused the disap-
pearance of both subunit e and g (Fig. 5E). Both Arg-8 and
Arg-107 are located next to the GXXXG dimerization
domains (Figs. 4 and 5F), and we suspect that this is the region
where the PTP forms.
The ATP20 Arg-107 mutation does not affect growth
properties, dimerization, and subunit composition of F-ATP
synthase
Given the importance of subunits e and g in both F-ATP
synthase dimerization and PTP formation in yeast (19), we
characterized the key features of the R107A mutants. Yeast cells
can grow by fermentation in glucose-rich medium, whereas
they need ATP generated from oxidative phosphorylation in
glycerol medium. The ATP20 R107A mutant grew both on the
glucose and glycerol (Fig. 6A), indicating that the mutation did
not influence the function of F-ATP synthase. The TIM11 and
ATP20 mutants expectedly did not display dimers after digi-
tonin extraction and blue native PAGE (Fig. 6B). Mitochondria
Table 1




number Positions in S. cerevisiae Positions in H. sapiens (M. musculus)
 26 4, 9, 67, 77, 127, 143, 163, 165, 176, 198, 201, 208, 225, 247,
295, 316, 323, 324, 328, 341, 345, 399, 410, 435, 457, 460
5, 12, 73, 83, 133, 149, 169, 171, 182, 204, 207, 214, 231, 253,
301, 322, 329, 330, 334, 347, 351, 405, 416, 441, 463, 466
 17 93, 105, 127, 139, 223, 225, 262, 264, 277, 293, 307, 328, 370,
389, 439, 441, 445
109, 121, 143, 155, 239, 241, 279, 281, 294, 310, 324, 345, 387,
406, 456, 458, 462
 7 4, 31, 42, 153, 266, 290, 292 4, 23, 34, 143, 253, 277, 279
a 1 186 159
c 1 39 c1: 99, c2: 104 (109), c3: 105 (104)
 2 5, 23 6, 24
OSCP 2 8, 114 14, 117
b 1 200 208
f 1 56 50 (44)
e 1 8 15
g 1 107 96
Total 60 60 60
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reexpressing either WT or R107A subunit g had functional
dimers indistinguishable from those of WT BY4743 cells (Fig.
6B) with identical subunit composition, as judged from SDS-
PAGE and silver staining (Fig. 6C). Thus, the R107A replace-
ment in subunit g did not influence the assembly, activity, and
stability of F-ATP synthase.
PGO reacts with Arg-107 of subunit g and affects the pore only
in mitochondria with the WT subunit
We next tested whether the PGO adduct affects the proper-
ties of the PTP. One emerging issue is pore size, which is
affected by the deletion of lateral stalk subunits OSCP and b
even when the CRC is apparently unaffected (24). We therefore
measured Ca2-induced swelling in yeast mitochondria in the
presence of ETH129 to allow electrophoretic Ca2 uptake. The
swelling rate was significantly inhibited by PGO in mitochon-
dria reexpressing WT subunit g but not the R107A mutant,
which displayed a lower rate of swelling (Fig. 7, A–C). Because
yeast subunit g also contains an arginine residue at position 106,
we employed synthetic test peptides corresponding to the
88 –114 amino acid segment of WT or containing the R106A
replacement. Following reaction with PGO, the peptides were
analyzed by MALDI-TOF MS. The results revealed that one
adduct with a molecular mass of 116 Da was formed on both the
WT and the R106A modified peptide (Fig. 7D). This molecular
mass corresponds to one molecule of PGO covalently attached
to the guanidine moiety of arginine. Formation of one single
adduct in the WT peptide carrying two adjacent arginines sug-
gests that reaction of Arg-107 with PGO may reduce the reac-
tivity of Arg-106.
Figure 2. Chemical modification of arginine residue(s) by PGO does not significantly affect activity, dimerization, and assembly of F-ATP synthase.
Experimental conditions were as described under “Experimental procedures.” A, ATP hydrolysis rate of MLM pretreated with DMSO (black bar) or with the
indicated concentrations of PGO (red bars). Closed bars, values subtracted for the oligomycin-insensitive fraction and expressed as nmol of ATP/mg/min. Open
bars, ATP hydrolysis in the presence of 4 M oligomycin. Results are mean  S.E. (error bars) of three independent experiments. B, oxygen consumption rate of
DMSO- or 2 mM PGO-pretreated MLM in presence of succinate (state 4) and ADP  Pi (state 3). Values refer to state 3/state 4 ratio and are expressed as mean 
S.E. of three independent experiments. C, ATP hydrolysis rate of YM isolated from WT strain BY4743 pretreated with DMSO (black bar) or with the indicated
concentrations of PGO (red bars). Values have been subtracted for the oligomycin-insensitive fraction and expressed as nmol of ATP/mg/min. Results are
mean  S.E. of at least three independent experiments. D, oxygen consumption rate of YM isolated from WT strain BY4743 pretreated with DMSO (black bar)
or with the indicated concentrations of PGO (red bars) in the presence of NADH and ADP. Values refer to the ratio of OCR (ADP) and OCR (NADH) and are
expressed as mean  S.E. of three independent experiments. E, isolated MLM pretreated with the concentrations of PGO labeling each lane were separated by
BN-PAGE as described under “Experimental procedures” and revealed with Coomassie Blue and in-gel activity staining for ATP hydrolysis to identify dimers (D),
monomers (M), and F1 sector of F-ATP synthase. F, dimers and monomers were cut out from BN-PAGE gels and subjected to SDS-PAGE and silver-stained. All
sets of lanes in E and F are from the same gels.
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Expression of human subunit g in yeast prevents
PGO-dependent desensitization of PTP
PGO desensitizes the yeast PTP to Ca2 (thus increasing the
CRC), whereas it sensitizes it in human HEK293 cells (thus
decreasing the CRC; see Fig. 1). We exploited this phenotypic
difference to test whether expression of human subunit g is able
to switch the inhibitory effect of PGO in yeast mitochondria to
the inducing effect seen in human mitochondria. Deletion of
the ATP20 gene encoding for yeast subunit g prevented
dimerization of F-ATP synthase, which could be rescued by
both expression of ATP20 and of ATP5L (which encodes
human subunit g) (Fig. 8A). As for WT yeast (compare with Fig.
1), PGO increased the CRC of ATP20 mitochondria reex-
pressing ATP20, whereas replacement with ATP5L totally pre-
vented the desensitizing effects of PGO, which rather decreased
the CRC (Fig. 8B), as also seen in permeabilized HEK293 cells.
These results suggest that subunit g confers species specificity
to the effects of PGO on the PTP.
Arg-107 of subunit g is a target for modification by high
glucose, phenylglyoxal, and methylglyoxal
Advanced glycation end-products (AGE) originate from
nonenzymatic modification of lysine and arginine residues that
takes place after long-term exposure to high concentrations of
glucose or to reactive compounds like methylglyoxal (MGO), a
byproduct of glycolysis that alters protein structure, stability,
and function (26 –28). Yeast cells grown at high glucose con-
centration undergo protein glycation largely due to generation
of high levels of MGO (29), with a relevant increase in argpy-
rimidine-modified proteins (30, 31). Arginine residues are fre-
quently found in enzyme sites involved in substrate binding and
catalysis, and their modification by MGO results in the forma-
tion of AGE (28). Consistent with these toxic effects, the growth
rate of yeast cells was slowed down in high-glucose medium
(Fig. 9A). At normal concentrations of glucose, toxicity was
mimicked by PGO and MGO (Fig. 9A). Remarkably, yeast
strains lacking subunit g or harboring the subunit g R107A
mutation were significantly more resistant to PGO toxicity (Fig.
9B).
Discussion
The molecular nature of the PTP is a long-standing mystery
of mitochondrial biology. In the past, we have used relatively
selective sulfhydryl, histidine, and arginine reagents to define
the properties of discrete sites conferring PTP regulation by the
proton electrochemical gradient, divalent cations, quinones,
and oxidative stress (8). The recent hypothesis that the PTP
may originate from a specific, Ca2-induced conformation of
F-ATP synthase (16 –19) provides a unique opportunity to
identify these sites in molecular terms. Indeed, mutagenesis of
specific residues or deletion of specific subunits of F-ATP syn-
thase should modify predictably the properties of the PTP
and/or the effect of reagents acting at these sites. This is a for-
midable challenge because F-ATP synthase is a complex multi-
subunit enzyme (32–37) whose assembly is affected by deletion
of specific subunits (23, 24). The present study is part of our
Figure 3. Expression of human OSCP does not alter the inhibitory effect of PGO on yeast PTP. A, isolated yeast mitochondria of the indicated
genotypes (50 g of protein/lane) were evaluated by Western blotting for , OSCP, TIM11, and ATP20 subunits. B, serial dilution spotting assay of the
indicated genotypes. Cell suspensions were grown to A600 nm  1; serially diluted; plated on medium containing 2% glucose (Glu), 2% Glu drop-out uracil
(uracil), and 2% glycerol; and incubated at 30 °C. Pictures were taken after 1–2 days. C, yeast mitochondrial proteins of the indicated genotypes were
separated by BN-PAGE as described under “Experimental procedures,” and revealed with Coomassie Blue and in-gel activity staining for ATP hydrolysis
to identify dimers (D), monomers (M), and F1 sector of F-ATP synthase. D, CRC of yeast mitochondria from ATP5  yOSCP (black bars) and ATP5 
yhOSCP (red bars) pretreated with the indicated concentrations of PGO. Data are expressed as CRC/CRC0 ratio, in which CRC0 refers to the CRC of
DMSO-treated mitochondria. Results are mean  S.E. (error bars) of at least three independent experiments. All sets of lanes in A and C are from the same
gels.
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efforts at identifying such regulatory sites and, as a corollary, at
(dis)proving the general hypothesis that the PTP originates
from F-ATP synthase. So far, we have provided evidence (i) that
Ca2 triggers the PTP by substituting Mg2 at the catalytic site,
causing a conformational change that is transmitted through
OSCP to the lateral stalk and eventually to the inner membrane
(21), and (ii) that PTP blockade by matrix H is mediated by the
unique, highly conserved histidine residue of OSCP subunit
(22). Here, we have been able to identify a unique arginine res-
idue that mediates the effects of PGO on the Ca2 sensitivity of
the PTP in yeast mitochondria.
Our previous studies had defined the PTP-modulatory
effects of arginine-selective reagents like glyoxals and 2,3-bu-
tanedione (12–15). Although glyoxals can also react with other
residues (such as lysines and cysteines) (38), it has been possible
to trace their effects on the PT to modification of arginines with
reasonable certainty (12–15). In rat liver mitochondria, the out-
come depended on the specific glyoxal used, with PTP inhibi-
tion by MGO or PGO and PTP activation by OH-PGO (12–15).
Studies with a variety of compounds with similar reactivity but
different overall physical-chemical properties led to the conclu-
sion that glyoxals react with the same arginine residue(s) and
Figure 4. Amino acid sequence comparison of F-ATP synthase subunits e and g.
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that the main determinants for the effects on the PTP are
charge and hydrogen-bonding capacity of the adducts (12–15).
Here, we have added the very relevant piece of information that
PGO has species-specific effects on the PTP. Having identified
Arg-107 of subunit g as the unique target of PGO in yeast, we
suspect that the species-specific effects may depend on differ-
ences in the primary structure of F-ATP synthase, which appear
to be particularly prominent in subunits e and g (Fig. 4).
A large fraction of the 60 conserved arginines of F-ATP syn-
thase is located in the catalytic sector (26 in subunit  and 17 in
subunit ) and in the F0 subunits , , c, and a (11 residues). The
membrane extrinsic region (F1 sector) of the F-ATP synthase
complex is composed of 3 and 3 and of one each of the , ,
and  subunits. The 33 hexamer contains the catalytic sites
responsible for ATP synthesis or hydrolysis (32) and associates
through the , , and  subunits with a ring of hydrophobic c
subunits (the c-ring) in the membrane domain. The rotating
c-ring is in contact with the static a subunit, which maintains a
specific pathway for translocation of protons through the mem-
brane (34). A conserved arginine residue of subunit a plays a
critical role in blocking a futile proton shortcut and in facilitat-
ing proton transfer at the a/c-ring interface via a carboxylic
group in the c-ring (39). Our data do not reveal whether the
arginine residues of the catalytic sector react with glyoxals, but
they do indicate that, if present, these adducts do not play a
direct role in PTP modulation.
OSCP plays a critical role in the assembly and function of
F-ATP synthase (40, 41) and has a well-characterized regula-
tory role in PTP modulation in mammals by providing a site for
CyPD binding, which results in sensitization of the PTP to Ca2
(17, 42, 43). Replacement of yeast with human OSCP did not
reverse PTP sensitization to Ca2 by PGO, however, suggesting
that also OSCP arginines are not critical for PTP modulation by
glyoxals.
F-ATP synthase complexes associate into dimers, which are
essential for the formation of oligomers and generation of the
cristae (44 –46). Subunits e and g are essential for this process,
and deletion of either subunit leads to dimer and cristae disrup-
tion (46 –52). The e and g subunits are also important for reg-
ulation of the Ca2 sensitivity of yeast PTP, which undergoes
desensitization after their genetic ablation (19). The fact that
their contribution has been so far addressed in null mutants
inevitably limits our understanding of their putative function in
PTP formation. Conversely, site-directed mutagenesis of spe-
cific residues that does not alter assembly, subunit composi-
tion, and enzymatic activity of the enzyme allows interrogation
of their role in PTP formation and regulation.
The yeast R107A mutant of subunit g described here shows
F-ATP synthase dimers with normal hydrolytic activity, yet it
displays a PTP that is desensitized to Ca2 (data not shown) and
insensitive to PGO and a decreased swelling rate in sucrose.
This last finding suggests that Arg-107 of subunit g may be
Figure 5. Arg-107 of yeast F-ATP synthase subunit g mediates the effects of PGO on the CRC. Experimental conditions were as in Fig. 1B. A, CRC of ATP20
yeast mitochondria pretreated with the indicated concentrations of PGO. B, CRC of TIM11 yeast mitochondria pretreated with the indicated concentrations
of PGO. C, CRC of yeast mitochondria from ATP20 WT control (black trace) and ATP20 R107A (red trace) pretreated with the indicated concentrations of PGO. *,
p  0.05 versus ATP20 WT; ***, p  0.001 versus ATP20 WT. Two-way ANOVA was used for statistical analysis. D, CRC of yeast mitochondria from TIM11 WT
control (black trace) and TIM11 R8A (red trace) pretreated with the indicated concentrations of PGO. In A–D, data are expressed as ratio to DMSO-treated
mitochondria. Means  S.E. (error bars) of at least three independent experiments are shown. E, isolated yeast mitochondria of the indicated genotypes were
evaluated by Western blotting for , TIM11, and ATP20 subunit content after SDS-PAGE separation of 50 g of protein per lane. F, overview of ATP synthase F0
dimer (Protein Data Bank code 6B2Z) with frontal and top views highlighting the relative position of subunits g (yellow) and e (light blue). Putative GXXXG
dimerization motifs are represented in purple. The structure is shown in standard view (front) and after a 90° rotation around the z axis, and two F0 monomers
are presented. The boxed region is expanded in the bottom part of the panel. Green spheres represent the position of Arg-8 of subunit e and Arg-107 of subunit
g, which are predicted to localize at the border of the GXXXG domains. These positions were derived by comparing data from the three-dimensional structure
(Protein Data Bank code 6B2Z) with secondary structure predictions.
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important for solute permeation through the PTP, providing a
further clue as to a possible site where the pore forms. Of note,
replacement of yeast subunit g with its human counterpart con-
fers the “human” phenotype to yeast, suggesting that the spe-
cies-specific effect of PGO is more likely to depend on struc-
tural differences between the yeast and human F-ATP synthase
than on the Arg-107–PGO adduct as such.
In mammals, dysregulated PTP opening is a primary cause of
cell death initiated via matrix swelling and rupture of the outer
membrane followed by release of proapoptotic factors (cyto-
chrome c), whereas its inhibition appears often to be protective
(8). Whether the pore plays a similar role in yeast is still a matter
of debate. Yeast does not possess a mitochondrial Ca2
uniporter to mediate rapid Ca2 overload; nor does it form the
apoptosome complex required for the activation of effector
caspases. However, yeast mitochondria can undergo mem-
brane permeabilization in response to Ca2 and oxidative
stress (53, 54), leading to the release of cytochrome c, which
certainly causes decreased respiration and ATP production.
These events, together with the activation of the yeast meta-
caspase Ycalp, are proximal events in yeast programmed cell
death (54). Thus, as for mammals, PTP opening might repre-
sent an important cell death pathway also for yeast, which can
undergo apoptosis and aging (55).
AGE arising from carbonyl stress contribute to many patho-
logical states, such as diabetes and age-related diseases (26 –28).
It is apparent that adducts form at many sites other than sub-
unit g, yet our findings suggest that altered PTP features may
play a role in glucose-dependent toxicity also in human cells, as
was already suggested (56). Whether additional arginine resi-
dues mediate the glyoxal-specific effects described in rat mito-
chondria and human cells (12–15) remains to be established.
However, the demonstration that a single conserved arginine
residue of subunit g mediates the effects of PGO on the PTP in
yeast is another step toward a molecular understanding of PTP
regulation and evidence that the latter forms from a specific
conformation of the F-ATP synthase.
Experimental procedures
Reagents and cells
PGO hydrate, MGO, oligomycin, rotenone, succinic acid,
pyruvate, alamethicin, ATP, ADP, EGTA, CaCl2, digitonin,
NADH, ETH129, galactose, and sucrose were from Sigma
(Milan, Italy). Cyclosporin A was purchased from Calbiochem.
Ca2 Green-5N was from Invitrogen (Milan, Italy). HEK293T
were obtained from the American Tissue Culture Collection
(ATCC) and cultured in Dulbecco’s modified Eagle’s medium
(Lonza, Basel, Switzerland) supplemented with fetal bovine
serum (10%) and penicillin and streptomycin (1%) (Thermo
Fisher Scientific). Drosophila Schneider S2 cells were obtained
from Dr. Michael Forte (Oregon Health and Science Univer-
sity) and cultured as described (57). The Saccharomyces cerevi-
siae strains BY4743, TIM11, and ATP20 were purchased
from Thermo Scientific, and mitochondria were isolated as
described (19). Antibodies for TIM11, ATP20, and  subunits
Figure 6. The ATP20 R107A mutation does not affect dimerization, assembly, and function of F-ATP synthase. A, serial dilution spotting assay of BY4743,
TIM11, ATP20, ATP20 WT, ATP20 R107A strains. Cell suspensions were grown to A600 nm  1; serially diluted; plated on medium containing 2% Glu, 2% Glu
drop-out uracil (uracil), and 2% glycerol; and incubated at 30 °C. Pictures were taken after 1–3 days. B, yeast mitochondrial proteins of the indicated
genotypes were separated by BN-PAGE as described under “Experimental procedures” and revealed with Coomassie Blue and in-gel activity staining for ATP
hydrolysis to identify dimers (D), monomers (M), and the F1 sector of F-ATP synthase. C, dimers and monomers were cut out from BN-PAGE, subjected to
two-dimensional SDS-PAGE, and revealed by silver staining. All sets of lanes in B and C are from the same gels.
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were a kind gift of Dr. Marie-France Giraud (University of Bor-
deaux, France). Antibody for the OSCP subunit was purchased
from Santa Cruz Biotechnology, Inc. (sc-365162).
Yeast mutant generation
To generate ATP5 yeast expressing the human or yeast
OSCP (ATP5) sequence, the ATP5 gene was first deleted in
W303 diploids by substituting the genomic sequence with the
Kan cassette of pFA6a-KanMX4 vector. Then diploids were
allowed to sporulate in 2% potassium acetate medium, resulting
tetrads were dissected, and correct clones were checked by
semiquantitative PCR using appropriate primers. Yeast ATP5
gene (yOSCP) was cloned in pFL38-URA vector after amplifi-
cation using the following primers that include upstream and
downstream regulatory sites (endogenous promoter and termi-
nation sequence): 5-CACGACGTTGTAAAACGACGGCC-
AGTGAATTCGAGCTCGGTACCCTGCCGTCGTCATAA-
AGTGGAC (forward) and 5-TTACGCCAAGCTTGCATGC-
CTGCAGGTCGACTCTAGAGGATCCCCGTTTGCCTGG-
ATACACGAAC (reverse). Cloned products were confirmed by
sequence analysis. Human OSCP (hOSCP) cDNA (NM_
001697) was purchased from GenScript and amplified using the
following primers: 5-CAGTGTGCTGGAATTCAACACA-
ATGGCTGCCCCAGCAGTGTCC (forward) and 5-GATA-
TCTGCAGAATTTTAGACAATCTCCCGCATAGCCCTG
(reverse). To substitute with the yeast putative mitochondrial
import sequence at the N terminus of the OSCP gene




and the same reverse primer as for hOSCP. PCR products were
cloned in pYES2-URA previously digested with EcoRI-HF
using the In-Fusion HD cloning kit (Clontech), and resulting
Figure 7. Arg-107 of yeast F-ATP synthase subunit g mediates inhibition of mitochondrial permeability transition by PGO. Experimental conditions
were as in Fig. 1B except that Ca2 green-5N was omitted. A and B, PTP-dependent mitochondrial swelling was evaluated as the decrease of absorbance at 540
nm, and the fraction of mitochondria that underwent the PT was assessed as described by Petronilli et al. (63). Additions of 50 M Ca2 and 5 M alamethicin
are indicated by arrows. Ca2 was omitted in the light blue traces. Mitochondria isolated from ATP20 WT (A) and ATP20 R107A yeast (B) were treated with DMSO
(black traces) or 4 mM PGO in DMSO (red traces). Representative traces of at least three independent experiments are shown. C, rate of mitochondrial swelling
triggered by 50 M Ca2. ATP20 WT or ATP20 R107A mitochondria were pretreated with DMSO (black bars) or 4 mM PGO (red bars). The rate of mitochondrial
swelling is expressed as the fraction of swollen mitochondria/min. Data are mean  S.E. (error bars) of at least three independent experiments. *, p  0.05 versus
WT (ATP20 WT); ***, p  0.001 versus vehicle. One-way ANOVA was used for statistical analysis. D, MALDI-TOF mass spectra of synthetic peptides of the amino
acid segment comprising Arg-107. The mass spectra of the parent peptides are shown in the top windows, and that of the PGO-modified peptides is shown in
the bottom window. Masses in the spectra are M  H. The 116-Da adducts are marked with arrows.
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vectors were checked by sequencing. Yeast ATP5 cells were
separately transformed by a standard procedure (58) with
yOSCP pFL38-URA, hOSCP pYES2-URA, or yhOSCP pYES2-
URA, and correct clones were selected. Human cDNA ATP5L
cloned into pESC-LEU vector by SalI/XhoI sites was purchased
from GenScript. The oligonucleotide primers used for the yeast
ATP20 gene to be cloned in pESC-LEU vector by SalI/XhoI sites
were 5-GGGCCCGGGCGTCGACAACACAATGCTAAGC-
AGGATCCAA (forward) and 5-ACCAAGCTTACTCGATT-
AGTGATGTTTATATCCCAC (reverse). PCR products were
cloned in pESC-LEU vector previously digested with SalI-HF
and XhoI using the In-Fusion HD cloning kit (Clontech), and
resulting vectors were checked by sequencing. A one-step
transformation protocol (58) was used to transform ATP5L
pESC-LEU or ATP20 pESC-LEU into yeast ATP20 strain and
cultured in the selective medium 2% galactose (drop-out leu-
cine). The oligonucleotide primers used for TIM11 R8A and
ATP20 R107A site-directed mutagenesis were as follows:
TIM11 R8A, 5-CGACAGTTAATGTTTTGGCATACTCTG-
CGTTGGGTTTG (forward) and 5-CAAACCCAACGCAG-
AGTATGCCAAAACATTAACTGTCG (reverse); ATP20
R107A, 5-CGGTGAAATAATTGGAAGAGCAAAATTAG-
TGGGATATAAAC (forward) and 5-GTTTATATCCCACT-
AATTTTGCTCTTCCAATTATTTCACCG (reverse).
The QuikChange Lightning site-directed mutagenesis kit
(Agilent) was used to harvest the mutants, and the dsDNA tem-
plates we used were TIM11 and ATP20 WT genes created in
pFL38 plasmid. After the mutations were confirmed by
sequencing, a one-step transformation protocol (58) was used
to transform the plasmid into TIM11 or ATP20 S. cerevisiae
strain and plated on the selective medium 2% Glu (drop-out
uracil) and incubated in 30 °C for 2 days.
Mouse liver mitochondria preparation
All of the isolation procedures were performed at 4 °C or
on ice. Mouse livers were cut into pieces in the isolation
buffer containing 250 mM sucrose, 10 mM Tris-HCl, 0.1 mM
EGTA, pH 7.4. The homogenate suspension was centrifuged
at 690 	 g for 10 min. The supernatant was collected and
centrifuged at 7000 	 g for 10 min. The pellet was suspended
in the isolation buffer and centrifuged at 9400 	 g for 5 min.
The mitochondria pellet was resuspended in about 400 l of
isolation buffer. The biuret test was used for determining
protein concentration.
Yeast mitochondria isolation
Yeast mitochondria were isolated as described previously
(19). Briefly, yeast cells were cultured in 400 ml of medium
containing 1% yeast extract, 1% bacto-polypeptone, and 2%
galactose overnight at 30 °C. Yeast cells were harvested by cen-
trifugation at 2000 	 g for 5 min at room temperature. The cell
pellet was incubated in 0.1 M Tris-SO4, pH 9.4, buffer, supple-
mented with 10 mM DTT for 15 min at 37 °C. The incubation
was terminated by centrifugation at 2000 	 g for 5 min and
washed once with 1.2 M sorbitol, 20 mM Pi, pH 7.4, buffer.
The cell pellet was resuspended in the above sorbitol buffer
supplemented with zymolyase (0.4 mg/g pellet) and then
incubated for 45 min at 30 °C. The incubation was termi-
nated by centrifugation at 2000 	 g for 5 min at 4 °C and
washed once with sorbitol buffer. The cell pellet was resus-
pended in cold buffer containing 0.6 M mannitol, 10 mM
Tris-HCl, 0.1 mM EDTA, pH 7.4, and homogenized with a
Potter homogenizer. The supernatant was collected and cen-
trifuged at 2000 	 g for 5 min at 4 °C, and then the superna-
tant was centrifuged at 12,000 	 g for 10 min at 4 °C. The
mitochondrial pellet was harvested in mannitol medium.
Protein concentration was quantified by the A280 of 0.6%
SDS-solubilized mitochondria.
Cell permeabilization
The culture medium of human HEK293 cells was discarded,
and cells were washed once with Dulbecco’s PBS. Cells were
Figure 8. Expression of human subunit g in yeast prevents the inhibitory effect of PGO. A, yeast mitochondrial proteins of the indicated genotypes were
separated by BN-PAGE as described under “Experimental Procedures” and revealed with Coomassie Blue and in-gel activity staining for ATP hydrolysis to
identify dimers (D), monomers (M), and F1 sector of F-ATP synthase. B, CRC of yeast mitochondria from ATP20  ATP20 (black trace) and ATP20  ATP5L (red
trace) pretreated with the indicated concentrations of PGO. Data are expressed as CRC/CRC0 ratio, in which CRC0 refers to the CRC of DMSO-treated mitochon-
dria. Results are mean  S.E. (error bars) of at least three independent experiments. *, p  0.05 versus vehicle; **, p  0.01 versus vehicle; ***, p  0.001 versus
vehicle. One-way ANOVA was used for statistical analysis.
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treated with 0.25% trypsin, and the reaction was terminated by
the addition of culture medium. Drosophila S2R cells were
detached with a scraper. Cell suspensions were centrifuged at
500 	 g for 5 min and washed once with medium containing
130 mM KCl, 10 mM MOPS-Tris, 1 mM Pi, 0.1 mM EGTA, pH
7.4. The cell pellet was resuspended in a medium containing
130 mM KCl, 10 mM MOPS-Tris, 1 mM Pi, 1 mM EGTA, pH 7.4,
and supplemented with 100 M digitonin and incubated for 10
min on ice at a density of 2 	 107 cells/ml (HEK293 cells) or
supplemented with 150 M digitonin and incubated on ice for
20 min at a density of 6 	 107 cells/ml (Drosophila S2R cells).
The incubations were terminated by dilution with 15–20 ml of
medium containing 130 mM KCl, 10 mM MOPS-Tris, 1 mM Pi,
0.1 mM EGTA, pH 7.4, followed by centrifugation at 500 	 g for
5 min at 4 °C. The cell pellet was washed once with 5 ml of the
above KCl medium at 4 °C. The final pellet was resuspended in
250 mM sucrose, 20 M EGTA, 10 mM HEPES-KOH, pH 8.0, for
reaction with PGO.
Chemical modification with PGO
Freshly isolated mouse liver or yeast mitochondria (1 mg/ml)
or 2 	 107/ml permeabilized cells were incubated with PGO in
250 mM sucrose, 20 M EGTA, 10 mM HEPES-KOH, pH 8.0, for
15 min at 25 °C. The reaction was terminated by decreasing the
pH to 6.8 with HEPES and cooling to 4 °C. Mitochondria were
precipitated by centrifugation at 8000 	 g for 6 min and washed
once with 250 mM sucrose, 0.1 mM EGTA, 0.5 mg/ml BSA, 10
mM Tris-HCl, pH 7.4. Mitochondria or cells were finally resus-
pended in the assay medium.
Mitochondrial Ca2 retention capacity
Yeast mitochondria (0.5 mg of protein/ml) were suspended
in 250 mM sucrose, 10 mM Tris-MOPS, 20 M EGTA, 1 mM
NADH, 5 M ETH129, 2 mM Pi, 1 M Calcium Green-5N, 0.5
mg/ml BSA, pH 7.4. MLM (0.5 mg of protein/ml) and permea-
bilized HEK293 or Drosophila S2R cells (1 	 107 cells/ml)
were suspended in 250 mM sucrose, 10 mM Tris-MOPS, 10 M
Figure 9. The ATP20 R107A yeast mutant is partially resistant to PGO toxicity. A, A600 nm values of WT strain BY4743 cultured in 2% glucose (black trace),
20% glucose (purple trace), 2% glucose with the addition of 16 mM MGO (green trace), or 2% glucose with the addition of 0.5 mM PGO (red trace) at the indicated
time points. B (left), A600 nm value of yeast WT strain BY4743 (blue trace), ATP20 mutant (purple trace), ATP20 WT control (black trace), or ATP20 R107A (red trace)
cultured in 2% glucose with the addition of 0.5 mM PGO. Right, survival of yeast cells incubated with 0.5 mM PGO at 30 °C for 6 h normalized to untreated
cultures. Data are mean  S.E. (error bars) of three independent experiments. ***, p  0.001 versus BY4743; §, p  0.001 versus ATP20 WT. One-way ANOVA was
used for statistical analysis.
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EGTA, 1 mM Pi, 0.5 M Calcium Green-5N, 5 mM succinate, 2
M rotenone, pH 7.4. Final volume was 0.2 ml. External Ca2
concentration was monitored by Calcium Green-5N fluores-
cence (excitation and emission wavelengths 485 and 538 nm,
respectively) using a Fluoroskan Ascent FL (Thermo Scientific)
plate reader.
Mitochondrial swelling assay
Isolated yeast mitochondria were suspended in 250 mM
sucrose, 10 mM Tris-MOPS, 20 M EGTA, 1 mM NADH, 5 M
ETH129, 0.5 mg/ml BSA, 2 mM Pi, pH 7.4, at a concentration of
0.5 mg of protein/ml in a final volume of 2 ml. Mitochondrial
swelling was measured as the decrease of the turbidity (appar-
ent absorbance at 540 nm) using a Cary 100 UV-visible spec-
trophotometer from Agilent Technologies.
Western blotting
Isolated mitochondria were lysed in 150 mM NaCl, 50 mM
Tris-HCl, pH 7.4, 2 mM EDTA, 2 mM EGTA, 1% Triton X-100,
10 mM -mercaptoethanol, 10% glycerol, 0.3% Nonidet P-40,
0.04% bromphenol blue, supplemented with protease inhibitor
mixture (Sigma) at 2.5 g of protein/l and boiled for 5 min.
The above lysates were loaded onto NuPAGETM 12% BisTris
protein gels (Invitrogen), and proteins were separated by elec-
trophoresis in NuPAGETM MOPS SDS running buffer (Invitro-
gen) for 3 h at 20 mA at 4 °C. Resolved proteins were transferred
to nitrocellulose membranes in NuPAGETM transfer buffer for
1.25 h at 30 V at 4 °C, followed by membrane blocking with 5%
(w/v) dry milk. The membrane was incubated overnight with
the antibodies for TIM11, ATP20, and  subunits overnight at
4 °C. Immunoreactive bands were detected by chemilumines-
cence using an Uvitec Cambridge instrument.
Blue native gel electrophoresis
Isolated yeast mitochondria were suspended in 150 mM
potassium acetate, 30 mM HEPES, 10% glycerol, 1 mM phenyl-
methylsulfonyl fluoride, supplemented with 1.5% (w/v) digito-
nin, pH 7.4, at 10 mg/ml, followed by centrifugation at
100,000 	 g for 25 min at 4 °C with a Beckman TL-100 rotor.
Supernatants were collected and supplemented with native
PAGE 5% G-250 sample additive (Invitrogen) and then rapidly
applied onto NativePAGETM NovexTM 3–12% BisTris protein
gels (Invitrogen). Electrophoresis was carried out in the Dark
Blue cathode buffer at 150 V for 20 min and in the Light Blue
cathode buffer at 250 V for 2 h. After electrophoresis, gels were
stained with Coomassie Blue or used for in-gel activity staining
of F-ATP synthase as described previously (19).
ATP hydrolysis assay
MLM or YM pretreated by PGO were suspended in 30 mM
sucrose, 50 mM KCl, 50 mM Tris-HCl, 2 mM EGTA, 4 mM MgCl2
and 2 mM phosphoenolpyruvate, supplemented with 4 units/ml
pyruvate kinase, 3 units/ml lactate dehydrogenase, 2 mM ATP,
and 0.3 mM NADH. Treatment with 4 M oligomycin was per-
formed at 37 °C for 15 min. The assay was carried out at 37 °C at
a protein concentration of 40 g 	 ml1 in a final volume of 0.2
ml. ATP synthesis was measured as the decrease of absorbance
of NADH at 340 nm using an Infinite 200 PRO multimode
microplate reader.
Oxygen consumption rate
A Clark oxygen electrode was used to detect the oxygen con-
sumption rate of isolated mitochondria. MLM were incubated
in 250 mM sucrose, 10 mM Tris-MOPS, 10 M EGTA, pH 7.4, at
a final concentration of 0.5 mg of protein/ml in a final volume of
2 ml. Further additions were 5 mM succinate as substrate, 1 mM
Pi, and 0.2 mM ADP. YM were incubated in 250 mM sucrose, 10
mM Tris-MOPS, 20 M EGTA, 5 mM Pi, 0.5 mg/ml BSA, pH 7.4,
at a final concentration of 0.25 mg of protein/ml in a final vol-
ume of 2 ml. Further additions were 1 mM NADH, 0.2 mM ADP,
and 4 M oligomycin.
Mass spectrometry of g subunit peptides
Peptides (amino acids 88 –114 of subunit g) modeled on the
native sequence or containing alanine at position 106 were pur-
chased from Caslo ApS (Kongens Lyngby, Denmark). Peptides
were dissolved at a concentration of 100 M in 10 mM Hepes-
K, pH 8.0, and allowed to react with 2 mM PGO at room tem-
perature for 60 min. The reaction was stopped by the addition
of 0.5% TFA. The peptides were separated from the reaction
mixture by reverse phase chromatography using C18 ZipTips
(Millipore) pre-equilibrated with 0.5% TFA. Bound peptides
were eluted with 10 l of 60% acetonitrile and 0.5% TFA. The
eluate was concentrated to 1 l under a stream of nitrogen,
mixed with 1 l of a saturated solution of -cyano-4-hydroxy-
cinnamic acid, and applied to the MALDI target plate. MALDI-
TOF was performed on a Bruker Ultraflextreme (Bremen, Ger-
many) mass spectrometer operating in positive reflectron
mode. Calibration of the instrument was performed using pep-
tides of known mass.
Secondary structure assignment
This was performed pairing predictions from PSIPRED (59)
and FELLS (60), whereas transmembrane regions were pre-
dicted with TMHMM (61). Default parameters were selected.
The three-dimensional structure was visualized with Chimera
(62).
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